ConductScience.org, home

Paper9174176

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.

Hoggard PG and 4 others. Antimicrob Agents Chemother, 1997. Cited by 124 papers, by iCite.

Cite this record

ConductScience Library. Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Papers, record 9174176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9174176

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
124
iCite
Relative citation ratio, by iCite
3.52
iCite
Revised in PubMed
2020-07-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoggard PGP G
2Kewn SS
3Barry MGM G
4Khoo SHS H
5Back DJD J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
StavudineMajor topic
Cells, Cultured
Drug Interactions
Humans
Leukemia, Monocytic, Acute
Leukocytes, Mononuclear
Phosphorylation
Phytohemagglutinins
Stimulation, Chemical
Thymidine
Zidovudine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17861017Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.J Infect Dis1995https://conductscience.org/library/papers/7861017PubMed
27833221Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.Br J Clin Pharmacol1994https://conductscience.org/library/papers/7833221PubMed
37574535Drug interactions with zidovudine phosphorylation in vitro.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7574535PubMed
48568296Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro.J Infect Dis1996https://conductscience.org/library/papers/8568296PubMed
58724049Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylation.AIDS1996https://conductscience.org/library/papers/8724049PubMed
68902065The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.AIDS1996https://conductscience.org/library/papers/8902065PubMed
74813080Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses.J Clin Pharmacol1974https://conductscience.org/library/papers/4813080PubMed
8541423Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol.J Chromatogr1979https://conductscience.org/library/papers/541423PubMed
96610522Fluoxetine kinetics and protein binding in normal and impaired renal function.Clin Pharmacol Ther1984https://conductscience.org/library/papers/6610522PubMed
103028398Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.Biochem Biophys Res Commun1987https://conductscience.org/library/papers/3028398PubMed
112435003Ribavirin antagonizes the effect of azidothymidine on HIV replication.Science1987https://conductscience.org/library/papers/2435003PubMed
123568539Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.Clin Pharmacol Ther1987https://conductscience.org/library/papers/3568539PubMed
133495235Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3495235PubMed
143648476The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.Mol Pharmacol1987https://conductscience.org/library/papers/3648476PubMed
153120727Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.Biochem Pharmacol1987https://conductscience.org/library/papers/3120727PubMed
163435108
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.
Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3435108PubMed
1725364411-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent.J Med Chem1989https://conductscience.org/library/papers/2536441PubMed
182852679Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.J Clin Pharmacol1988https://conductscience.org/library/papers/2852679PubMed
192539371Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.J Biol Chem1989https://conductscience.org/library/papers/2539371PubMed
202470825Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.J Immunol Methods1989https://conductscience.org/library/papers/2470825PubMed

See all 31 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
27044763KASL clinical practice guidelines: management of hepatitis C.Clin Mol Hepatol2016https://conductscience.org/library/papers/27044763PubMed
26537918Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord.BMC Infect Dis2015https://conductscience.org/library/papers/26537918PubMed
25032178KASL clinical practice guidelines: management of hepatitis C.Clin Mol Hepatol2014https://conductscience.org/library/papers/25032178PubMed
24550342Intracellular effects of the Hepatitis C virus nucleoside polymerase inhibitor RO5855 (Mericitabine Parent) and Ribavirin in combination.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24550342PubMed
22344296A quantitative basis for antiretroviral therapy for HIV-1 infection.Nat Med2012https://conductscience.org/library/papers/22344296PubMed
21115794In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21115794PubMed
20000887Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.Clin Pharmacokinet2010https://conductscience.org/library/papers/20000887PubMed
19330875Diagnosis, management, and treatment of hepatitis C: an update.Hepatology2009https://conductscience.org/library/papers/19330875PubMed
19273671
Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir.
Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19273671PubMed
19043930Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.Antivir Ther2008https://conductscience.org/library/papers/19043930PubMed
18160521The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18160521PubMed
17638393Nucleoside and nucleotide reverse transcriptase inhibitors in children.Clin Drug Investig2007https://conductscience.org/library/papers/17638393PubMed
17517847In vitro interactions between apricitabine and other deoxycytidine analogues.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17517847PubMed
17501757Therapeutic issues in HIV/HCV-coinfected patients.J Viral Hepat2007https://conductscience.org/library/papers/17501757PubMed
17242147Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17242147PubMed
16495240Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16495240PubMed
16189072
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study.
Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16189072PubMed
16091233Hepatitis C virus infection in HIV-infected patients.Curr HIV/AIDS Rep2004https://conductscience.org/library/papers/16091233PubMed
15855513Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15855513PubMed
15727735Management of Hepatitis C in HIV-infected Patients.Curr Infect Dis Rep2005https://conductscience.org/library/papers/15727735PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9174176

GET https://conductscience.org/api/papers/v1/9174176/references?page=2